Biotech remains a strong opportunity for 2021, says Jefferies' Michael Yee

Michael Yee, Jefferies managing director, joins CNBC's "Closing Bell" to discuss the biotech sector's busy year, with companies such as Moderna racing to complete a Covid-19 vaccine and others looking for coronavirus treatments.
Tue, Dec 29 20205:47 PM EST